Chemical formula: C₁₅H₁₇N₅O₆S₂ Molecular mass: 427.455 g/mol PubChem compound: 6335986
Like other beta-lactam drugs, cefpodoxime exerts antibacterial activity by binding to and inhibiting the action of certain bacterial cell wall synthetic enzymes, namely the penicillin binding proteins.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J01DD13 | Cefpodoxime | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| CEFPODOXIME PROXETIL Granule, for suspension | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| CEFPODOXIME LUPIN Powder for oral suspension | MPI, EU: SmPC |
Cefpodoxime is an active ingredient of these brands:
Austria (AT)
Croatia (HR)
France (FR)
Hong Kong (HK)
Italy (IT)Japan (JP)
Malta (MT)
Mexico (MX)
Nigeria (NG)
Romania (RO)South Africa (ZA)
Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
